prednisolone has been researched along with Bone Diseases, Metabolic in 29 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite a far lower cumulative GC dose in comparison with patients treated with systemic corticosteroids continuously, after adjusting for BMI and lung function, osteoporosis of the lumbar spine was most frequent in patients receiving > 1,000 mg of prednisolone cumulatively, administered in multiple courses for the treatment of exacerbations of COPD." | 3.71 | Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. ( Dekhuijzen, PN; Dubois, EF; Röder, E; Schweitzer, DH; Zwinderman, AE, 2002) |
| "At the distal radius, osteopenia was found in all the groups." | 2.69 | Bone loss in long-term renal transplantation: histopathology and densitometry analysis. ( Adams, JE; Crowley, V; Cueto-Manzano, AM; France, MW; Freemont, AJ; Gokal, R; Hutchison, AJ; Konel, S; Mawer, B, 1999) |
| "Investigations revealed distal renal tubular acidosis with severe metabolic bone disease as an extra-glandular manifestation of primary SS." | 1.56 | Primary Sjogren's syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease. ( Bhandari, S; Jain, G; Kalra, S; Vasnik, G, 2020) |
| " No relationship was observed between osteoporosis and age, sex, body mass index, duration of hemodialysis therapy, cumulative dosage of any drugs, or use of pulsed methylprednisolone therapy." | 1.35 | Osteoporosis and related risk factors in renal transplant recipients. ( Ahmadpoor, P; Ghafari, A; Makhdoomi, K; Rahimi, E; Reisi, S; Sepehrvand, N, 2009) |
| "Osteoporosis or osteopenia was present in all the diagnostic groups." | 1.35 | Cytokines, bone turnover markers and weight change in candidates for lung transplantation. ( Bjørtuft, O; Boe, J; Førli, L; Halse, J; Mellbye, OJ; Vatn, M, 2008) |
| " Those receiving a higher CsA dosage (<2." | 1.33 | Bone mineral density in long-term Chinese heart transplant recipients: a cross-sectional study. ( Chen, YH; Chou, NK; Kuo, HL; Su, IC; Wang, SS; Yang, RS, 2006) |
| "Osteopenia was common in both groups (44." | 1.32 | Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone. ( Drexel, H; Gouya, G; Hergan, K; Höfle, G; Holzmüller, H; Hubmann, M; Langer, P, 2003) |
| "Rat models of osteopenia include ovariectomy and long-term glucocorticoid treatment." | 1.31 | Comparison of osteopenia after gastrectomy, ovariectomy and prednisolone treatment in the young female rat. ( Andersson, N; Håkanson, R; Lehto-Axtelius, D; Surve, VV, 2001) |
| " The aim of the present study was to evaluate if growth hormone administration would have an anabolic effect on rat bone when given to animals also receiving a high dosage of glucocorticoid." | 1.29 | Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect. ( Andreassen, TT; Brüel, A; Ortoft, G; Oxlund, H, 1995) |
| "Radiologic or clinical evidence of osteopenia in the spine was not found." | 1.28 | Limitations of quantitative CT in corticosteroid induced osteopenia. ( Glaros, D; Kalef-Ezra, J; Karantanas, AH, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 12 (41.38) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, G | 1 |
| Kalra, S | 1 |
| Vasnik, G | 1 |
| Bhandari, S | 1 |
| Ohlsson, C | 1 |
| Nilsson, KH | 1 |
| Henning, P | 1 |
| Wu, J | 1 |
| Gustafsson, KL | 1 |
| Poutanen, M | 1 |
| Lerner, UH | 1 |
| Movérare-Skrtic, S | 1 |
| Bhadada, SK | 1 |
| Dhaliwal, R | 1 |
| Dhiman, V | 1 |
| Rao, SD | 1 |
| Jensen, EA | 1 |
| White, AM | 1 |
| Liu, P | 1 |
| Yee, K | 1 |
| Waber, B | 1 |
| Monk, HM | 1 |
| Zhang, H | 1 |
| Ahmadpoor, P | 1 |
| Reisi, S | 1 |
| Makhdoomi, K | 1 |
| Ghafari, A | 1 |
| Sepehrvand, N | 1 |
| Rahimi, E | 1 |
| Sharma, A | 1 |
| Pinto Pereira, LM | 1 |
| Capildeo, K | 1 |
| Charles, K | 1 |
| Teelucksingh, S | 1 |
| Ding, M | 1 |
| Cheng, L | 1 |
| Bollen, P | 1 |
| Schwarz, P | 1 |
| Overgaard, S | 1 |
| Kriel, M | 1 |
| Sayers, A | 1 |
| Fraser, WD | 1 |
| Williams, AM | 1 |
| Koch, A | 1 |
| Zacharowski, K | 1 |
| Probert, CS | 1 |
| Tobias, JH | 1 |
| Tang, XL | 1 |
| Qin, L | 1 |
| Kwok, AW | 1 |
| Zhu, TY | 1 |
| Kun, EW | 1 |
| Hung, VW | 1 |
| Griffith, JF | 1 |
| Leung, PC | 1 |
| Li, EK | 1 |
| Tam, LS | 1 |
| Höfle, G | 1 |
| Holzmüller, H | 1 |
| Gouya, G | 1 |
| Hergan, K | 1 |
| Hubmann, M | 1 |
| Langer, P | 1 |
| Drexel, H | 1 |
| Lian, KC | 1 |
| Lang, TF | 1 |
| Keyak, JH | 1 |
| Modin, GW | 1 |
| Rehman, Q | 1 |
| Do, L | 1 |
| Lane, NE | 1 |
| Chou, NK | 1 |
| Su, IC | 1 |
| Kuo, HL | 1 |
| Chen, YH | 1 |
| Yang, RS | 1 |
| Wang, SS | 1 |
| Kikuchi, Y | 1 |
| Imakiire, T | 1 |
| Yamada, M | 1 |
| Saigusa, T | 1 |
| Hyodo, T | 1 |
| Kushiyama, T | 1 |
| Higashi, K | 1 |
| Hyodo, N | 1 |
| Yamamoto, K | 1 |
| Suzuki, S | 1 |
| Miura, S | 1 |
| Førli, L | 1 |
| Mellbye, OJ | 1 |
| Halse, J | 1 |
| Bjørtuft, O | 1 |
| Vatn, M | 1 |
| Boe, J | 1 |
| Unoki, E | 1 |
| Ortoft, G | 2 |
| Oxlund, H | 2 |
| Brüel, A | 1 |
| Andreassen, TT | 1 |
| Okazaki, Y | 1 |
| Tsurukami, H | 1 |
| Nishida, S | 1 |
| Okimoto, N | 1 |
| Aota, S | 1 |
| Takeda, S | 1 |
| Nakamura, T | 1 |
| Ebeling, PR | 1 |
| Thomas, DM | 1 |
| Erbas, B | 1 |
| Hopper, JL | 1 |
| Szer, J | 1 |
| Grigg, AP | 1 |
| Cueto-Manzano, AM | 1 |
| Konel, S | 1 |
| Hutchison, AJ | 1 |
| Crowley, V | 1 |
| France, MW | 1 |
| Freemont, AJ | 1 |
| Adams, JE | 1 |
| Mawer, B | 1 |
| Gokal, R | 1 |
| Ozaki, D | 1 |
| Shirai, Y | 1 |
| Nakayama, Y | 1 |
| Yoshihara, K | 1 |
| Huzita, T | 1 |
| Lange, U | 1 |
| Boss, B | 1 |
| Teichmann, J | 1 |
| Stracke, H | 1 |
| Neeck, G | 1 |
| Belvisi, MG | 1 |
| Wicks, SL | 1 |
| Battram, CH | 1 |
| Bottoms, SE | 1 |
| Redford, JE | 1 |
| Woodman, P | 1 |
| Brown, TJ | 1 |
| Webber, SE | 1 |
| Foster, ML | 1 |
| Matsumoto, H | 1 |
| Ishihara, K | 1 |
| Hasegawa, T | 1 |
| Umeda, B | 1 |
| Niimi, A | 1 |
| Hino, M | 1 |
| Surve, VV | 1 |
| Andersson, N | 1 |
| Lehto-Axtelius, D | 1 |
| Håkanson, R | 1 |
| Dubois, EF | 1 |
| Röder, E | 1 |
| Dekhuijzen, PN | 1 |
| Zwinderman, AE | 1 |
| Schweitzer, DH | 1 |
| Karantanas, AH | 1 |
| Kalef-Ezra, J | 1 |
| Glaros, D | 1 |
| Geusens, P | 1 |
| Dequeker, J | 1 |
| Nijs, J | 1 |
| Verstraeten, A | 1 |
| Bramm, E | 1 |
| Graziani, G | 1 |
| Aroldi, A | 1 |
| Castelnovo, C | 1 |
| Bondatti, F | 1 |
| DeVecchi, A | 1 |
| Ponticelli, C | 1 |
1 review available for prednisolone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Fibrogenesis Imperfecta Ossium.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Collagen; Diphosphonates; Di | 2019 |
2 trials available for prednisolone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.
Topics: Adolescent; Adult; Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Dose-Response R | 2007 |
Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
Topics: Absorptiometry, Photon; Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bone Density; Bo | 1999 |
26 other studies available for prednisolone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Primary Sjogren's syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
Topics: Absorptiometry, Photon; Acidosis, Renal Tubular; Adolescent; Antirheumatic Agents; Arthralgia; Bone | 2020 |
WNT16 overexpression partly protects against glucocorticoid-induced bone loss.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Cytoprotection; Female; Glucocorticoids; Mice; Mice | 2018 |
Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
Topics: Birth Weight; Bone Diseases, Metabolic; Bronchopulmonary Dysplasia; Comorbidity; Female; Furosemide; | 2016 |
Osteoporosis and related risk factors in renal transplant recipients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Creatinine; Cyclo | 2009 |
Steroid-induced iatrogenic disease after treating for pseudothrombocytopenia.
Topics: Bone Diseases, Metabolic; Diabetes Mellitus; Diagnostic Errors; Glucocorticoids; Humans; Hyperglycem | 2011 |
Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Biomarkers; Bone and Bones; Bone Diseases, M | 2010 |
IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease.
Topics: Adult; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Cell Proliferation; Collagen Type | 2010 |
Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
Topics: Absorptiometry, Photon; Adult; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Case | 2013 |
Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone.
Topics: Bone Density; Bone Diseases, Metabolic; Collagen; Cross-Sectional Studies; Cyclosporine; Drug Therap | 2003 |
Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women.
Topics: Absorptiometry, Photon; Age Factors; Aged; Aged, 80 and over; Bone Density; Bone Diseases, Metabolic | 2005 |
Bone mineral density in long-term Chinese heart transplant recipients: a cross-sectional study.
Topics: Adult; Aged; Body Size; Bone Density; Bone Diseases, Metabolic; Cross-Sectional Studies; Cyclosporin | 2006 |
Cytokines, bone turnover markers and weight change in candidates for lung transplantation.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Body Weight; Bone Density; Bone Diseases, Metabolic; C- | 2008 |
[Effect of human PTH on steroid-induced osteopenia: a histomorphometric study of decalcified and undecalcified trabecular bone sections in rat].
Topics: Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; Osteogenesis; Parathyroid H | 1995 |
Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.
Topics: Administration, Oral; Aging; Animals; Bone Density; Bone Development; Bone Diseases, Metabolic; Bone | 1996 |
Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Female; Fem | 1995 |
Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats.
Topics: Animals; Arthritis, Experimental; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Collagen; | 1998 |
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cross-Sectional Studies; Cyclosporin | 1999 |
Multiple fish vertebra deformity in child with systemic lupus erythematosus: a case report.
Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcitonin; Child; Female; Humans; | 2000 |
Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica--a prospective study on the influence of glucocorticoid therapy.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bone Den | 2000 |
Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Bone Diseases, Metabolic; Budesonide; Desox | 2001 |
Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study.
Topics: Absorptiometry, Photon; Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Ast | 2001 |
Comparison of osteopenia after gastrectomy, ovariectomy and prednisolone treatment in the young female rat.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Disease Models, Animal; Femur; Gastrectomy; Ovariec | 2001 |
Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Anti-Inflammatory Agents; Body Mass Index; Bone | 2002 |
Limitations of quantitative CT in corticosteroid induced osteopenia.
Topics: Adult; Bone Diseases, Metabolic; Collagen Diseases; Female; Humans; Kidney Transplantation; Male; Mi | 1991 |
Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Drug Therapy, Combination; Estradiol; Female; Hydro | 1991 |
Ciclosporin and calcium metabolism in renal transplanted patients.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Diseases, Metabolic; Calcium; Cyclosporins; Humans; Intes | 1991 |